Safety and Pharmacokinetics of Escalating Daily Doses of the Antituberculosis Drug Rifapentine in Healthy Volunteers

Схожие документы

• Population Pharmacokinetics of Rifapentine and Desacetyl Rifapentine in Healthy Volunteers: Nonlinearities in Clearance and Bioavailability
  по: Savic, Radojka M., et al.
  Опубликовано: (2014)
• Quantification of Rifapentine, a Potent Antituberculosis Drug, from Dried Blood Spot Samples Using Liquid Chromatographic-Tandem Mass Spectrometric Analysis
  по: Parsons, Teresa L., et al.
  Опубликовано: (2014)
• Novel Dosing Strategies Increase Exposures of the Potent Antituberculosis Drug Rifapentine but Are Poorly Tolerated in Healthy Volunteers
  по: Dooley, Kelly E., et al.
  Опубликовано: (2015)
• Repeated Administration of High-Dose Intermittent Rifapentine Reduces Rifapentine and Moxifloxacin Plasma Concentrations
  по: Dooley, Kelly, et al.
  Опубликовано: (2008)
• Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers
  по: Weiner, Marc, et al.
  Опубликовано: (2014)